Cortice Biosciences, Inc. - 30 Jul 2024 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
10%+ Owner
Signature
Cortice Biosciences, Inc., /s/ Michael Weiser, Director
Issuer symbol
CNSP
Transactions as of
30 Jul 2024
Net transactions value
$0
Form type
4
Filing time
06 Aug 2024, 17:11:50 UTC
Previous filing
06 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNSP Common Stock 573,368 30 Jul 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Cortice Biosciences, Inc. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed to report the termination of the Reporting Person's status as a section 16 reporting person as a result of an increase in the number of shares of Common Stock outstanding.